Clinical Readiness Study (vs. Clinical Trial)
**What it means:** A **"clinical readiness study"** is different from a full clinical trial. It's the work done *before* a trial to make sure the trial can actually happen. This includes: - **Patient ...
Explainers
Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.
Theripio Innovations (the startup)
**What it means:** Theripio Innovations is the **startup company** founded by Dr. Christopher Cowan at MUSC to commercialize the MEF2C RNA therapeutic platform. In drug development, when academic rese...
Preclinical Update (in gene therapy context)
**What it means:** "Preclinical" means research done **before human trials begin** — in cell cultures (in vitro) and animal models (in vivo). A "preclinical update" means the researchers have complete...
MEF2C Hilfsorganisation (German MEF2C organization)
**What it means:** "Hilfeorganisation" means "help organization" or "support organization" in German. MEF2C Hilfsorganisation e.V. is the German patient advocacy group for MEF2C families. The "e.V." (...
Inpart (Industry Partnering Platform)
**What it means:** Inpart is a **global scientific partnering platform** used by 90% of the world's top 50 pharmaceutical companies. Think of it as LinkedIn for drug development — it tracks which acad...
Longitudinal Data / Longitudinal Study
**What it means:** Longitudinal data is collected from the **same subjects repeatedly over time** — like taking photos of the same tree every year to watch it grow. This is different from a cross-sect...
Oncology / Solid Tumor (in CDK2 inhibitor context)
**What it means:** Oncology is the branch of medicine that deals with cancer. "Solid tumors" are cancers that form actual lumps or masses (as opposed to blood cancers like leukemia). Breast, ovarian, ...
Oncologic Biomarker Context for MHS
**What it means:** A biomarker is a measurable biological indicator. In cancer, biomarkers (like ctDNA, tumor size on imaging, or protein levels in blood) tell doctors how the cancer is responding to ...
First-in-Human (FIH) Trial
**What it means:** This is the **very first time a drug is given to people** — never humans before, only animals (and cell cultures). It's essentially Phase 1a. The goals are: 1. **Safety** — does the...
Natural History Study
**What it means:** A natural history study systematically tracks a disease **without giving any treatment**. It's like creating a detailed map of a territory before you try to change it — you need to ...
PFS (Progression-Free Survival)
**What it means:** PFS is a common clinical trial metric. It measures **how long patients live without their disease getting worse** — specifically, without the cancer growing or spreading. It's measu...
NEDHSIL (Neurodevelopmental Disorder with Hypotonia, Stereotypic Hand Movements, and Impaired Language)
**What it means:** NEDHSIL is the **alternative name** for MEF2C-associated syndrome. It describes the core clinical features without naming the gene. You might see it in older papers or clinical note...
Retrospective Study
**What it means:** A retrospective study looks **backward in time** at existing data — reviewing past patient records, genetic test results, and clinical outcomes to find patterns. It's less rigorous ...
Phase 1a/b Clinical Trial
**What the phases mean:** - **Phase 1a:** First-in-human testing. The primary goal is **safety** — "Is this drug safe in humans at all?" A small group of patients receives escalating doses to find the...